Asplenia and functional hyposplenism in autoimmune polyglandular syndrome type 1

Area of Science:

• Endocrinology
• Immunology
• Genetics

Background:

• Autoimmune polyendocrine syndrome type-I (APS-I) is a rare genetic disorder characterized by autoimmune attacks on multiple endocrine glands.
• Asplenia, or the absence of splenic function, is a recognized but not fully understood complication of APS-I.

Observation:

• Four patients diagnosed with APS-I presented with asplenia.
• Two affected patients were children (aged 2-4 years) from the same family.
• Two adult patients, including the father of the children and his cousin, also had APS-I and asplenia.

Findings:

• A progressive decline in splenic function was observed in the pediatric patients over a follow-up period.
• The study highlights a potential correlation between APS-I and the development or worsening of splenic dysfunction.

Implications:

• Patients with APS-I require regular assessment of splenic function.
• Early detection of splenic dysfunction is critical for timely therapeutic interventions, especially in pediatric cases.
• Understanding this association may lead to improved management strategies for APS-I patients, reducing risks associated with impaired splenic function.